uniQure N.V. Quarterly Income Statement
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
uniQure N.V. revenue and earnings
In the quarter ended Mar 31, 2026, uniQure N.V. generated $3.6 million in revenue, up 127.3% from the same quarter a year earlier. uniQure N.V. reported a net loss of $53.5 million, compared with a loss of $43.6 million a year earlier. Gross margin was 93.9% (up from 87.4%) and operating margin -1283.5%.
Diluted earnings per share came in at -$0.85.
Summary generated from market data by MetaCap's automated system. Methodology
uniQure N.V. income statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.56M | 5.57M | 3.70M | 5.26M | 1.57M | 5.22M | 2.29M | 11.13M | 8.48M | 6.69M | 1.41M | 2.42M |
| Revenue growth (YoY) | +127.31% | +6.65% | +61.83% | -52.71% | -81.53% | -21.95% | +62.54% | +359.37% | +59.34% | -93.49% | -2.90% | +387.32% |
| Cost of Revenue | 219.00K | 435.00K | 398.00K | 656.00K | 197.00K | 619.00K | 264.00K | 234.00K | 150.00K | — | — | — |
| Gross Profit | 3.34M | 5.13M | 3.30M | 4.61M | 1.37M | 4.60M | 2.02M | 10.89M | 8.34M | — | — | — |
| Operating Expenses | 49.06M | 56.25M | 54.34M | 48.47M | 40.70M | 50.43M | 42.25M | 54.90M | 62.56M | — | — | — |
| Research & Development | 29.18M | 34.78M | 34.37M | 35.38M | 36.14M | 38.84M | 30.59M | 33.66M | 40.69M | 42.62M | 65.40M | 46.04M |
| Selling, General & Admin | 20.07M | 21.61M | 19.44M | 13.50M | 10.91M | 11.38M | 11.57M | 15.77M | 13.94M | 17.49M | 18.07M | 21.18M |
| Operating Income | -45.72M | -51.12M | -51.03M | -43.87M | -39.33M | -45.83M | -40.23M | -44.01M | -54.23M | -61.75M | -81.88M | -65.07M |
| Interest Expense | 14.03M | 14.57M | 16.72M | 15.59M | 15.11M | 14.88M | 16.61M | 16.16M | 16.10M | 15.71M | 15.44M | 6.84M |
| Other Income (Expense) | 3.77M | 18.13M | -7.22M | — | — | — | — | — | — | — | — | — |
| Pretax Income | -53.05M | -41.00M | -71.90M | -37.29M | -43.14M | -72.41M | -44.41M | -55.35M | -64.96M | -70.17M | -89.64M | -68.31M |
| Income Tax | 488.00K | -3.92M | 8.63M | 425.00K | 496.00K | 856.00K | -31.00K | 948.00K | 656.00K | 3.03M | -69.00K | 163.00K |
| Net Income | -53.53M | -37.09M | -80.53M | -37.72M | -43.64M | -73.26M | -44.38M | -56.30M | -65.62M | -73.21M | -89.57M | -68.47M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | -1175.45% | — | — |
| EPS (Basic) | -0.85 | -0.57 | -1.38 | -0.69 | -0.82 | -1.49 | -0.91 | -1.16 | -1.36 | -1.52 | -1.88 | -1.44 |
| EPS (Diluted) | -0.85 | -0.57 | -1.38 | -0.69 | -0.82 | -1.49 | -0.91 | -1.16 | -1.36 | -1.52 | -1.88 | -1.44 |
| Shares Outstanding (Basic) | 62.74M | — | 58.52M | 54.81M | 53.11M | — | 48.72M | 48.62M | 48.38M | — | 47.77M | 47.65M |
| Shares Outstanding (Diluted) | 62.74M | — | 58.52M | 54.81M | 53.11M | — | 48.72M | 48.62M | 48.38M | — | 47.77M | 47.65M |
| EBITDA | -42.76M | -48.15M | -47.40M | -40.23M | -34.80M | -41.47M | -37.24M | -41.34M | -51.60M | -57.56M | -79.28M | -62.49M |
| Gross Margin | 93.85% | 92.19% | 89.25% | 87.53% | 87.43% | 88.14% | 88.46% | 97.90% | 98.23% | — | — | — |
| Operating Margin | -1283.55% | -918.07% | -1378.95% | -833.62% | -2509.96% | -877.76% | -1758.99% | -395.56% | -639.10% | -923.13% | -5819.26% | -2686.79% |
| Net Margin | -1502.95% | -666.06% | -2175.87% | -716.82% | -2784.75% | -1403.20% | -1940.45% | -506.01% | -773.34% | -1094.42% | -6366.10% | -2827.17% |
This table shows 12 quarterly periods of uniQure N.V.'s income statement, from Q1 2026 back to Q2 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow QURE's reporting calendar. What is a income statement?